- Report
- August 2024
- 141 Pages
Global
From €3810EUR$3,899USD£3,180GBP
- Report
- May 2024
- 128 Pages
Global
From €6350EUR$6,499USD£5,301GBP
- Report
- July 2024
- 196 Pages
Global
From €4641EUR$4,750USD£3,874GBP
- Report
- February 2024
- 110 Pages
Global
From €4641EUR$4,750USD£3,874GBP
- Report
- July 2024
- 150 Pages
Global
From €2565EUR$2,625USD£2,141GBP
€3664EUR$3,750USD£3,059GBP
- Drug Pipelines
- July 2024
- 180 Pages
Global
From €1710EUR$1,750USD£1,427GBP
€2443EUR$2,500USD£2,039GBP
- Report
- June 2024
- 200 Pages
Global
From €5437EUR$5,565USD£4,539GBP
€7768EUR$7,950USD£6,485GBP
- Report
- June 2024
- 200 Pages
Global
From €5437EUR$5,565USD£4,539GBP
€7768EUR$7,950USD£6,485GBP
- Clinical Trials
- June 2024
- 240 Pages
Global
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- April 2024
- 152 Pages
Global
From €2702EUR$2,765USD£2,255GBP
€3859EUR$3,950USD£3,222GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1368EUR$1,400USD£1,142GBP
€1954EUR$2,000USD£1,631GBP
- Drug Pipelines
- January 2024
- 136 Pages
Global
From €5130EUR$5,250USD£4,282GBP
€7328EUR$7,500USD£6,118GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1026EUR$1,050USD£856GBP
€1466EUR$1,500USD£1,224GBP
- Report
- September 2024
- 181 Pages
Global
From €4397EUR$4,500USD£3,671GBP
- Report
- May 2024
- 182 Pages
Global
From €4397EUR$4,500USD£3,671GBP
- Report
- July 2024
- 100 Pages
Global
From €2565EUR$2,625USD£2,141GBP
€3664EUR$3,750USD£3,059GBP
- Report
- July 2024
- 100 Pages
Global
From €2565EUR$2,625USD£2,141GBP
€3664EUR$3,750USD£3,059GBP
- Report
- October 2024
- 140 Pages
Global
From €2443EUR$2,500USD£2,039GBP
- Report
- March 2024
- 200 Pages
Global
From €4055EUR$4,150USD£3,385GBP
- Report
- April 2024
- 160 Pages
Global
From €5861EUR$5,999USD£4,893GBP
The Asthma Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of medications used to treat asthma. Asthma is a chronic respiratory condition that affects the airways, causing difficulty breathing, coughing, and wheezing. Asthma drugs are designed to reduce inflammation in the airways, making it easier for patients to breathe. These drugs can be taken orally, inhaled, or injected, depending on the severity of the condition. Common asthma drugs include corticosteroids, bronchodilators, and leukotriene modifiers.
Some of the major companies in the Asthma Drugs market include GlaxoSmithKline, Merck & Co., Novartis, Pfizer, and Sanofi. These companies are involved in the research, development, and marketing of asthma drugs, as well as the production of generic versions of existing drugs. They also provide support services to patients, such as educational materials and access to specialists. Show Less Read more